Stay updated with breaking news from Abuse Deterrent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 The...
MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the THREE MONTHS ENDED February 28, 2023 The following...
Company Remains on Track to Report Results the End of MarchSAN DIEGO, CA / ACCESSWIRE / February 28, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage biotech
Completion of Clinical Portion Represents Critical Milestone Towards CommercializationNasal Opioid Abuse Being Explored for PF614Data From Trial Expected in September 2022SAN DIEGO, CA / ACCESSWIRE / August
Press release content from Accesswire. The AP news staff was not involved in its creation.